All Articles

Compare FACT and AABB accreditation for stem cell banking: scope, regulatory status, quality requirements, and what families should check for lab safety.

Compare slow-cooling, vitrification, and controlled-rate freezing for cord blood—trade-offs in CD34+ recovery, viability, oxidative stress, and storage risk.

Explains how stem cell therapy can regenerate heart tissue after a heart attack, improve LVEF, reduce heart failure risk, and current delivery challenges.

Banked cord blood and therapies like DUOC-01 show strong trial results—faster availability, lower rejection risk, and improved outcomes for many rare genetic disorders.

Cord blood and tissue stem cell therapies show early safety and promise for repairing lung and brain injuries in newborns with BPD, HIE, and IVH.

MSC therapies for degenerative disc disease: mechanisms, clinical results and safety, and emerging exosome, biomaterial, gene-editing, and stem cell banking advances.

Five essential questions—accreditation, storage, pricing, medical uses, and financial stability—to evaluate cord blood banks before your baby's birth.

Explains how cord blood banking preserves newborn stem cells for 80+ treatments today and supports future adult therapies through long-term storage.

Store cord blood (HSCs) and cord tissue (MSCs) to preserve blood, immune and regenerative stem cells for current treatments and future therapies.